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Dr Vinay Badhwar (Pittsburgh, Pa). I want to first announce
that Dr Lawrance is a PGY2 and he should be congratulated on
an excellent presentation.
Dr Lawrance and colleagues at Washington University provide
us with an excellent review of their experience with 252 Cox maze
IV operations performed via sternotomy compared with 104 per-
formed via a rib-sparing, video-assisted right minithoracotomy
for the surgical treatment of atrial fibrillation between 2002 and
2014. You and your colleagues are to be commended for teaching
us so much in this field and your continued leadership.
To corroboratively frame your study’s findings, at The Center
for Atrial Fibrillation at the University of Pittsburgh, we share
your embrace of nearly the identical minimally invasive approach
to the Cox maze IV with similar results.
I have 2 questions. Your study design is a retrospective cohort
analysis to really detect noninferiority betweenminimally invasive
and sternotomy approaches for the Cox maze IV. In order to
approximate similarity between the groups, in the manuscript,
instead of a multivariable regression or perhaps a propensity score
analysis, you elected to apply only 12 preoperative variables for a
univariate comparison. It seems that the sternotomy group had
larger atria, lower ejection fraction, more mitral valve replace-
ments, more tricuspid valve operations, less paroxysmal atrial
fibrillation, and a trend toward more persistent atrial fibrillation.
This suggests that the sternotomy group may have a higher
comorbid profile.
Although the longitudinal AF outcome comparison between
minithoracotomy and sternotomy Cox maze seems to be valid
and equally excellent, perhaps the acute outcome comparisons
of 30-day mortality, morbidity, and ICU time may be less fair
without a multivariable or propensity score analysis between
groups. Why were only 12 preoperative variables used in your
comparison?
Dr Lawrance. Thank you, Dr Badhwar, for the excellent
question. More than 400 variables from the STS database and
our custom longitudinal database were recorded on all patients.
We performed a preliminary analysis of these results, and chose
to perform a formal statistical analysis on variables that were either
clinically significant or appeared to be statistically.
Since the time of submission of our abstract, we have actually
included 5 additional variables in our preoperative analysis
including stroke, peripheral vascular disease, chronic lung disease,
renal failure, and dialysis. As we have shown in our presentation,
there were no additional differences between groups when
including these variables.
Despite these similarities, the 2 groups may still be different and
a proper comparison could only be performed in the setting of a
randomized trial. Here we simply present the data from our study.rdiovascular Surgery c Volume 148, Number 3 961
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DDr Badhwar. As the senior author knows very well, the evi-
dence-based mission in surgical education for atrial fibrillation
treatment is really to encourage more surgeons to perform surgical
ablation, particularly the Cox maze IV procedure, when AF exists
at the time of a structural operation.
For some surgeons, early in the learning curve, transitioning
from sternotomy to minimally invasive thoracotomy for isolated
mitral operations, occasionally the existence of atrial fibrillation
and the need to perform a maze procedure may be a nonstarter
and pose a potential obstacle either to abort a minimally invasive
approach for the mitral operation or perhaps cause them to perform
fewer lesions in a non–evidence-based manner.
It seems that the value of this important paper is to support the
principles outlined by others, that a full Cox maze IV lesion set is
indeed possible via a minithoracotomy approach and noninferior
to a sternotomy. What did your group find was the case number
learning curve for the effective performance and application of a
right minimally invasive Cox maze IV?
Dr Lawrance. Thank you again for the excellent question.
That is a difficult question to answer given our institutional
experience with the Cox maze IV procedure. We have performed
a preliminary analysis looking at crossclamp times and cardio-
pulmonary bypass times comparing patients at the beginning of
the study period to patients at the end of the study period and found
that there was no difference. However, because the morbidity was962 The Journal of Thoracic and Cardiovascular Surglow in both groups and we had no mortality in our right minithor-
acotomy group, the study was not powered to compare early
complication rates between patients at the beginning and end of
the study period. Therefore, it is difficult to discuss a learning
curve.
In addition, most of these cases at our center were performed by
1 surgeon, who is an expert in the Cox maze IV procedure and
had been performing a right minithoracotomy approach for
mitral valve procedures several years before the beginning of
the study period. So it is unlikely that a learning curve
established from this study would really translate well to other
institutions.
Dr Richard Lee (St Louis, Mo). I have no disclosures. I
congratulate you on a very nice study and a very nice presentation.
Our group has previously done a comparison of a classic maze
versus a hybrid approach using a different lesion set. We found,
however, even in the classic maze group therewas a 10% incidence
of subsequent late catheter ablation; in addition, there were many
more subsequent cardioversions. Did you look at the number of
cardioversions and/or catheter ablations in both groups after a
procedure, and if so, how were those data managed?
Dr Lawrance. Thank you Dr Lee for the question. We did not
specifically look at those data during this study. However, we do
have that data available in our database and will be able to provide
that to you in the near future.ery c September 2014
